Related Experiment Video
Updated: Nov 8, 2025

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Dantrolene-Induced Hepatitis: A Rare Culprit in the PICU
Divij Pasrija1, Shilpi Gupta2, Amanda Hassinger1
1Department of Pediatric Critical Care, Oishei Children's Hospital, University of Buffalo, Buffalo, New York, United States.
Abstract:
Dantrolene is used for reversal of malignant hyperthermia and for improvement in spasticity following stroke which are Food and Drug Administration-approved indications. It is an infrequently used medication in the pediatric intensive care unit and is usually continued from the operating room or sedation suite after suspicion for malignant hyperthermia, secondary to other medications and anesthetic agents. Hepatitis has been described as a side effect of the medication after prolonged use and at doses of more than 100 mg/d mainly in adults. We described in this case report a patient in which the drug was used for sympathetic overactivity in the PICU and development of asymptomatic hepatitis on day 3 after starting the medication at a dose much lower than previously described.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care

